Table 1 Experimental and control groups.

Group	Mice	Animal model	GC treatment	Follow‐up (days)
A	C57/Bl	Colitis	+	14
B	C57/Bl	Colitis	–	14
C	C57/Bl	Naive	+	14
D	C57/Bl	Naive	–	14
E	Athymic C57/Bl	HCC	+	54
F	Athymic C57/Bl	HCC	–	54
G	Athymic C57/Bl	Naive	+	54
H	Athymic C57/Bl	Naive	–	54

GC, β‐glucosylceramide; HCC, hepatocellular carcinoma.